603567.SS
603567.SS
CNE100002219
HEILONGJIANG ZBD PHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 798.063.745 2.706.503.666
70.5%
Cost of Revenue 820.121.909 1.215.053.991
32.5%
Gross Profit -22.058.164 1.491.449.675
101.5%
395.800.331 633.187.799
37.5%
Operating Income -417.858.495 858.261.876
148.7%
Pretax Income -1.627.401.874 523.471.915
410.9%
Net Income Common Stockholders -1.366.528.672 438.216.196
411.8%
-- --
--
-- --
--
ende